trial · primary record
Sutetinib Maleate Capsule
Non-small Cell Lung Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 128 |
| Primary completion | 2028-12 |
| Primary endpoint | Assessment of Objective response rate (ORR) |
| Registry ID | NCT05168566 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:24.515Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05168566
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.